{
    "hands_on_practices": [
        {
            "introduction": "A crucial first step in validating any quantitative assay is to determine its analytical sensitivity, which defines the lowest concentration of an analyte it can reliably measure. This practice will guide you through calculating the Limit of Detection (LOD) and Limit of Quantitation (LOQ), two fundamental metrics that establish the lower bounds of an assay's performance. By working through this problem , you will learn how to translate baseline signal noise into concrete concentration thresholds, a critical skill for assessing an ELISA's fitness for any diagnostic or research purpose.",
            "id": "5112170",
            "problem": "A laboratory is validating the analytical sensitivity of an Enzyme-Linked Immunosorbent Assay (ELISA) for a soluble protein biomarker using a microplate reader with absorbance reported in absorbance units (AU) at a wavelength selected for the enzyme chromogen. Near the low-concentration regime, the signal response of a well-constructed sandwich ELISA can be approximated by a locally linear relationship between absorbance and analyte concentration, which follows from the initial-region linearization of binding-driven signal generation under conditions where the fraction of occupied binding sites is small relative to the total available sites. Assume the following experimentally characterized baseline and calibration features for the assay:\n- The mean blank absorbance is $0.050$ AU with a blank standard deviation $\\sigma_{\\text{blank}} = 0.005$ AU, estimated from replicate measurements of a zero-analyte matrix processed through the full assay workflow.\n- The local slope of the calibration curve in the vicinity of low concentrations is $0.20$ AU per $\\text{ng}/\\text{mL}$, obtained from a linear fit to low-level calibrators without forcing the intercept and confirmed to be applicable in the concentration interval of interest.\n\nIn molecular and immunodiagnostics, the point at which an analyte is considered detected is defined as the smallest concentration whose expected signal is statistically distinguishable from the blank, using a criterion of $k$ times the blank standard deviation above the mean blank signal. For the Limit of Detection (LOD), take $k=3$; for the Limit of Quantitation (LOQ), take $k=10$, reflecting a more stringent requirement for quantitative reliability.\n\nAssuming Gaussian-distributed baseline noise and that the low-concentration linearization holds, compute the concentrations corresponding to the LOD and LOQ in $\\text{ng}/\\text{mL}$. Round both concentrations to three significant figures. Express your final results in $\\text{ng}/\\text{mL}$.",
            "solution": "The problem statement has been evaluated and is deemed valid. It is scientifically grounded in the principles of immunodiagnostics and analytical chemistry, well-posed with all necessary information provided, and objective in its language. The problem describes a standard procedure for determining the Limit of Detection (LOD) and Limit of Quantitation (LOQ) for an assay.\n\nThe fundamental task is to convert an absorbance threshold, defined statistically, into a corresponding analyte concentration using the provided calibration model.\n\nLet the mean blank absorbance be denoted by $A_{\\text{blank}}$ and its standard deviation by $\\sigma_{\\text{blank}}$. The provided values are:\n$A_{\\text{blank}} = 0.050$ AU\n$\\sigma_{\\text{blank}} = 0.005$ AU\n\nThe problem defines the absorbance threshold, $A_{\\text{threshold}}$, for a concentration to be considered detected or quantifiable as the mean blank signal plus $k$ times the standard deviation of the blank.\n$$A_{\\text{threshold}} = A_{\\text{blank}} + k \\cdot \\sigma_{\\text{blank}}$$\nThe value of the factor $k$ is given for the LOD and LOQ:\nFor the LOD, $k_{\\text{LOD}} = 3$.\nFor the LOQ, $k_{\\text{LOQ}} = 10$.\n\nThe relationship between the measured absorbance, $A(C)$, and the analyte concentration, $C$, is stated to be locally linear. The signal response can be modeled as:\n$$A(C) = m \\cdot C + A_{\\text{blank}}$$\nHere, $m$ represents the slope of the calibration curve (the assay's sensitivity), given as $m = 0.20$ AU per $\\text{ng}/\\text{mL}$. The term $m \\cdot C$ represents the net absorbance signal above the baseline blank that is attributable to the analyte concentration $C$.\n\nTo determine the concentration corresponding to the LOD or LOQ, we equate the model signal $A(C)$ to the defined threshold signal $A_{\\text{threshold}}$:\n$$m \\cdot C + A_{\\text{blank}} = A_{\\text{blank}} + k \\cdot \\sigma_{\\text{blank}}$$\nSubtracting $A_{\\text{blank}}$ from both sides of the equation yields the relationship for the net signal:\n$$m \\cdot C = k \\cdot \\sigma_{\\text{blank}}$$\nSolving for the concentration $C$ gives the general expression for the concentration limit:\n$$C = \\frac{k \\cdot \\sigma_{\\text{blank}}}{m}$$\n\nWe now apply this formula to calculate $C_{\\text{LOD}}$ and $C_{\\text{LOQ}}$.\nFirst, for the Limit of Detection (LOD), we substitute $k = k_{\\text{LOD}} = 3$, $\\sigma_{\\text{blank}} = 0.005$, and $m = 0.20$:\n$$C_{\\text{LOD}} = \\frac{3 \\cdot 0.005}{0.20} = \\frac{0.015}{0.20} = 0.075$$\nThe units are $(\\text{AU}) / (\\text{AU} / (\\text{ng}/\\text{mL})) = \\text{ng}/\\text{mL}$. The problem requires rounding to three significant figures, which yields $C_{\\text{LOD}} = 0.0750 \\text{ ng}/\\text{mL}$.\n\nSecond, for the Limit of Quantitation (LOQ), we substitute $k = k_{\\text{LOQ}} = 10$, $\\sigma_{\\text{blank}} = 0.005$, and $m = 0.20$:\n$$C_{\\text{LOQ}} = \\frac{10 \\cdot 0.005}{0.20} = \\frac{0.050}{0.20} = 0.25$$\nThe units are again $\\text{ng}/\\text{mL}$. Rounding to three significant figures gives $C_{\\text{LOQ}} = 0.250 \\text{ ng}/\\text{mL}$.\n\nThe calculated concentrations for the LOD and LOQ are $0.0750 \\text{ ng}/\\text{mL}$ and $0.250 \\text{ ng}/\\text{mL}$, respectively.",
            "answer": "$$\\boxed{\\begin{pmatrix} 0.0750 & 0.250 \\end{pmatrix}}$$"
        },
        {
            "introduction": "Beyond simply detecting an analyte, a high-quality assay must also be specific, accurately measuring the target molecule without interference from structurally similar compounds. This exercise delves into the concept of cross-reactivity, a critical measure of an assay's specificity that quantifies this interference. In this problem , you will model how a homologous protein can generate a false signal and calculate the resulting measurement error, providing essential insight into troubleshooting and interpreting complex biological samples.",
            "id": "5112171",
            "problem": "A laboratory is using a sandwich Enzyme-Linked Immunosorbent Assay (ELISA) to quantify a target protein, denoted as $T$, in human serum. The assay employs a capture antibody immobilized on the plate and a detection antibody conjugated to an enzyme, generating a signal upon addition of substrate. A homologous protein, denoted as $H$, is known to bind the detection antibody with nonzero affinity, leading to cross-reactivity.\n\nAssume the following scientifically standard foundation:\n- Under low-occupancy conditions typical of the linear dynamic range of a well-designed sandwich ELISA, the expected number of formed ternary complexes (capture antibody–$T$–detection antibody) and the resulting signal are proportional to the effective molar concentration of species that can bridge the capture and detection antibodies. Thus, the signal, $S$, can be modeled as $S = \\alpha \\sum_{i} k_{i} C_{i}$, where $C_{i}$ is the molar concentration of species $i$, $k_{i}$ is a proportionality constant that reflects the effective bridging efficiency for species $i$ (determined by the product of relevant microscopic association terms in the low-concentration limit), and $\\alpha$ is a detection proportionality constant.\n- Cross-reactivity between $H$ and the detection antibody is empirically defined at equimolar concentrations as follows: when $C_{T} = C_{H}$ and both are within the low-occupancy regime, the signal attributable to $H$ alone is a fixed fraction of the signal attributable to $T$ alone. Specifically, at equimolar concentrations, $S_{H}/S_{T} = r$, where $r$ is the cross-reactivity fraction.\n\nIn a particular validation, the homolog $H$ exhibits $10\\%$ cross-reactivity with $T$ at equimolar concentration under the same assay conditions, i.e., $r = 0.10$. In a clinical sample, the homolog $H$ is present at twice the molar concentration of the target, i.e., $C_{H} = 2 C_{T}$. The assay calibration and quantitation algorithm assume that all signal arises exclusively from $T$, so the reported concentration is computed from the total signal $S$ using the calibration factor corresponding to $T$.\n\nUsing the foundations above and the low-occupancy linearity, derive an expression for the measured concentration $C_{\\text{meas}}$ reported by the assay in terms of $C_{T}$, $r$, and $C_{H}$, and from it determine the relative error defined as $\\varepsilon = (C_{\\text{meas}} - C_{T})/C_{T}$ for the given conditions $r = 0.10$ and $C_{H} = 2 C_{T}$. Express the final relative error as a decimal fraction with no units and do not round.",
            "solution": "The problem is deemed valid as it is scientifically grounded in the principles of immunodiagnostics, is well-posed with a clear and consistent set of assumptions and givens, and is expressed in objective, formalizable language. There are no contradictions, ambiguities, or violations of scientific or mathematical principles.\n\nThe total signal, $S_{\\text{total}}$, measured in the sample arises from two sources: the target protein, $T$, and the cross-reacting homologous protein, $H$. According to the provided signal model for low-occupancy conditions, the signal is proportional to the concentration of the bridging species. The model is given as $S = \\alpha \\sum_{i} k_{i} C_{i}$.\n\nApplying this model to the two species in the sample, the total signal can be expressed as the sum of the individual signals:\n$$\nS_{\\text{total}} = S_{T} + S_{H}\n$$\nwhere $S_{T}$ is the signal from the target protein and $S_{H}$ is the signal from the homologous protein. Using the linear model, these are:\n$$\nS_{T} = \\alpha k_{T} C_{T}\n$$\n$$\nS_{H} = \\alpha k_{H} C_{H}\n$$\nHere, $C_T$ and $C_H$ are the true molar concentrations of the target and homolog, respectively. The constants $k_T$ and $k_H$ represent the specific bridging efficiencies for $T$ and $H$ in the sandwich assay format, and $\\alpha$ is the overall detection proportionality constant.\n\nThe total signal is therefore:\n$$\nS_{\\text{total}} = \\alpha k_{T} C_{T} + \\alpha k_{H} C_{H}\n$$\nTo proceed, we must establish a relationship between $k_T$ and $k_H$. The problem provides an empirical definition for cross-reactivity, $r$. It states that at equimolar concentrations, say $C_{\\text{equiv}}$, the ratio of the signal from $H$ alone to the signal from $T$ alone is $r$.\n$$\nr = \\frac{S_{H}(\\text{at } C_{H}=C_{\\text{equiv}})}{S_{T}(\\text{at } C_{T}=C_{\\text{equiv}})}\n$$\nSubstituting the linear signal model into this definition:\n$$\nr = \\frac{\\alpha k_{H} C_{\\text{equiv}}}{\\alpha k_{T} C_{\\text{equiv}}} = \\frac{k_{H}}{k_{T}}\n$$\nThis gives us the crucial relationship between the efficiency constants: $k_{H} = r k_{T}$.\n\nWe can now substitute this relationship back into the expression for the total signal:\n$$\nS_{\\text{total}} = \\alpha k_{T} C_{T} + \\alpha (r k_{T}) C_{H}\n$$\nFactoring out the common terms $\\alpha$ and $k_T$:\n$$\nS_{\\text{total}} = \\alpha k_{T} (C_{T} + r C_{H})\n$$\nThe problem states that the assay's quantitation algorithm is calibrated for $T$ only and assumes all signal arises from $T$. The calibration establishes a relationship between signal and concentration of the form $S = (\\alpha k_{T}) C$, where the term $(\\alpha k_{T})$ is a constant calibration factor (the slope of the standard curve in the linear range). The measured concentration, $C_{\\text{meas}}$, is therefore calculated by taking the measured total signal, $S_{\\text{total}}$, and applying this calibration relationship in reverse:\n$$\nC_{\\text{meas}} = \\frac{S_{\\text{total}}}{\\alpha k_{T}}\n$$\nSubstituting our expression for $S_{\\text{total}}$:\n$$\nC_{\\text{meas}} = \\frac{\\alpha k_{T} (C_{T} + r C_{H})}{\\alpha k_{T}}\n$$\nThe constants $\\alpha$ and $k_T$ cancel, yielding the general expression for the apparent measured concentration:\n$$\nC_{\\text{meas}} = C_{T} + r C_{H}\n$$\nNext, we must calculate the relative error, $\\varepsilon$, which is defined as:\n$$\n\\varepsilon = \\frac{C_{\\text{meas}} - C_{T}}{C_{T}}\n$$\nSubstituting our derived expression for $C_{\\text{meas}}$:\n$$\n\\varepsilon = \\frac{(C_{T} + r C_{H}) - C_{T}}{C_{T}} = \\frac{r C_{H}}{C_{T}}\n$$\nThe problem provides specific conditions for the validation scenario: the cross-reactivity fraction is $r = 0.10$, and the homolog concentration is twice the target concentration, $C_{H} = 2 C_{T}$. We substitute these values into the expression for the relative error:\n$$\n\\varepsilon = \\frac{(0.10) (2 C_{T})}{C_{T}}\n$$\nAssuming $C_{T} \\neq 0$ (which is necessary for the relative error to be well-defined), the term $C_T$ cancels from the numerator and the denominator:\n$$\n\\varepsilon = 0.10 \\times 2 = 0.20\n$$\nThe relative error in the measurement under the specified conditions is $0.20$.",
            "answer": "$$\\boxed{0.20}$$"
        },
        {
            "introduction": "This final practice moves from evaluating assay performance to the complex challenge of rational assay design. Here, you will step into the role of an assay developer, tasked with selecting the optimal pair of capture and detection antibodies to construct a high-performance sandwich ELISA. This exercise  synthesizes core principles including binding affinity ($K_D$), specificity, and epitope compatibility, challenging you to make a data-driven decision that maximizes the desired signal while minimizing background from off-target interactions.",
            "id": "5112222",
            "problem": "A laboratory seeks to configure a sandwich Enzyme-Linked Immunosorbent Assay (ELISA) for an analyte with three candidate monoclonal antibodies, labeled $A_1$, $A_2$, and $A_3$. The sandwich architecture uses one antibody as the capture reagent and a second, distinct antibody as the detection reagent. The sample contains a target antigen $T$ at concentration $[T]$ and a structurally related off-target antigen $O$ at concentration $[O]$. Assume equilibrium binding to each antigen follows a one-site Langmuir model. Define the fractional occupancy of antibody $A_i$ on antigen $X \\in \\{T,O\\}$ as\n$$\n\\theta_i^{X} = \\frac{[X]}{[X] + K_D^{(i,X)}} ,\n$$\nwhere $K_D^{(i,X)}$ is the equilibrium dissociation constant of $A_i$ for antigen $X$. In a sandwich assay, the expected probability that both capture $A_i$ and detection $A_j$ are simultaneously bound to $T$ is modulated by epitope non-overlap, represented by a factor $s_{ij} \\in [0,1]$; similarly, non-overlap can constrain accessibility on $O$. Pairwise competition experiments were performed by pre-incubating antigen with $A_i$ at saturating conditions and measuring the fractional inhibition of binding by $A_j$. Let $c_{ij}$ denote the fractional inhibition of $A_j$ by $A_i$. Model the non-overlap factor as\n$$\ns_{ij} = 1 - \\max(c_{ij}, c_{ji})\n$$\nfor $i \\neq j$, and take $s_{ii} = 0$ (a single antibody cannot serve as both capture and detection in a sandwich). Detection signal scales linearly with the detection antibody’s label efficiency $\\eta_j$. Assume the net objective to be maximized is the difference between the expected target-mediated signal and off-target-mediated background, each proportional to the joint binding probability of capture and detection, and scaled by $\\eta_j$. Use only fundamental binding and probability arguments to construct the needed expressions; do not invoke any unprovided shortcuts.\n\nThe following experimentally determined parameters are available:\n\n- Target and off-target concentrations: $[T] = 2\\,\\mathrm{nM}$ and $[O] = 10\\,\\mathrm{nM}$.\n- Dissociation constants to the target: $K_D^{(1,T)} = 0.5\\,\\mathrm{nM}$, $K_D^{(2,T)} = 2.0\\,\\mathrm{nM}$, $K_D^{(3,T)} = 1.0\\,\\mathrm{nM}$.\n- Dissociation constants to the off-target: $K_D^{(1,O)} = 30\\,\\mathrm{nM}$, $K_D^{(2,O)} = 200\\,\\mathrm{nM}$, $K_D^{(3,O)} = 100\\,\\mathrm{nM}$.\n- Pairwise competition (fractional inhibitions): $c_{12} = 0.60$, $c_{21} = 0.40$, $c_{13} = 0.10$, $c_{31} = 0.05$, $c_{23} = 0.70$, $c_{32} = 0.65$.\n- Detection label efficiencies: $\\eta_1 = 1.0$, $\\eta_2 = 1.3$, $\\eta_3 = 0.8$.\n\nFor assay feasibility, impose a compatibility threshold $\\tau$ such that viable pairs satisfy $s_{ij} \\ge \\tau$ with $\\tau = 0.35$. Construct the epitope compatibility matrix $S = [s_{ij}]$, determine all oriented capture–detection pairs $(A_i, A_j)$ with $i \\neq j$ that meet $s_{ij} \\ge \\tau$, and, using a principled derivation from the provided base, compute the net objective for each viable oriented pair. Select the oriented pair that maximizes the net objective under the compatibility constraint.\n\nTo report the result in a single number, use the following integer code for oriented pairs:\n- $p = 1$ for $(A_1, A_2)$,\n- $p = 2$ for $(A_1, A_3)$,\n- $p = 3$ for $(A_2, A_1)$,\n- $p = 4$ for $(A_2, A_3)$,\n- $p = 5$ for $(A_3, A_1)$,\n- $p = 6$ for $(A_3, A_2)$.\n\nProvide the integer $p$ corresponding to the optimal oriented pair. No rounding is required. The final answer must be the single integer $p$ as specified.",
            "solution": "The problem is first subjected to validation to ensure its scientific and logical integrity.\n\n### Step 1: Extract Givens\nThe following data, definitions, and conditions are explicitly provided:\n-   **Assay Type**: Sandwich Enzyme-Linked Immunosorbent Assay (ELISA).\n-   **Reagents**: Candidate monoclonal antibodies $A_1$, $A_2$, and $A_3$. One serves as capture, a distinct one as detection.\n-   **Antigens**: Target antigen $T$ at concentration $[T]$, off-target antigen $O$ at concentration $[O]$.\n-   **Binding Model**: One-site Langmuir model.\n-   **Fractional Occupancy**: $\\theta_i^{X} = \\frac{[X]}{[X] + K_D^{(i,X)}}$, where $X \\in \\{T,O\\}$.\n-   **Epitope Non-Overlap Factor**: $s_{ij} \\in [0,1]$ for a capture antibody $A_i$ and detection antibody $A_j$.\n-   **Competition Data**: $c_{ij}$ is the fractional inhibition of binding by $A_j$ when pre-incubated with saturating $A_i$.\n-   **Non-Overlap Model**: $s_{ij} = 1 - \\max(c_{ij}, c_{ji})$ for $i \\neq j$, and $s_{ii} = 0$.\n-   **Signal Scaling**: Detection signal scales linearly with label efficiency $\\eta_j$.\n-   **Objective Function**: Maximize the difference between the expected target-mediated signal and off-target-mediated background. Each signal component is proportional to the joint binding probability and scaled by $\\eta_j$.\n-   **Concentrations**: $[T] = 2\\,\\mathrm{nM}$, $[O] = 10\\,\\mathrm{nM}$.\n-   **Dissociation Constants (Target)**: $K_D^{(1,T)} = 0.5\\,\\mathrm{nM}$, $K_D^{(2,T)} = 2.0\\,\\mathrm{nM}$, $K_D^{(3,T)} = 1.0\\,\\mathrm{nM}$.\n-   **Dissociation Constants (Off-Target)**: $K_D^{(1,O)} = 30\\,\\mathrm{nM}$, $K_D^{(2,O)} = 200\\,\\mathrm{nM}$, $K_D^{(3,O)} = 100\\,\\mathrm{nM}$.\n-   **Fractional Inhibitions**: $c_{12} = 0.60$, $c_{21} = 0.40$, $c_{13} = 0.10$, $c_{31} = 0.05$, $c_{23} = 0.70$, $c_{32} = 0.65$.\n-   **Label Efficiencies**: $\\eta_1 = 1.0$, $\\eta_2 = 1.3$, $\\eta_3 = 0.8$.\n-   **Compatibility Threshold**: Viable pairs must satisfy $s_{ij} \\ge \\tau$, with $\\tau = 0.35$.\n-   **Task**: Construct the matrix $S=[s_{ij}]$, find all viable oriented pairs $(A_i, A_j)$, compute the net objective for each, and select the optimal pair.\n-   **Output Format**: An integer code $p$ for the optimal pair: $p=1$ for $(A_1, A_2)$, $p=2$ for $(A_1, A_3)$, $p=3$ for $(A_2, A_1)$, $p=4$ for $(A_2, A_3)$, $p=5$ for $(A_3, A_1)$, $p=6$ for $(A_3, A_2)$.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed for validity.\n-   **Scientifically Grounded**: The problem is based on the well-established principles of sandwich ELISA, equilibrium binding (Langmuir model), and antibody competition. The parameters (concentrations, dissociation constants) are within realistic ranges for typical immunoassays.\n-   **Well-Posed**: The problem provides a clear objective (maximization of a defined function) and a complete set of parameters and constraints. The existence of a solution is guaranteed as it involves finding the maximum of a function over a finite set of candidates. The uniqueness of the maximum is probable given the real-numbered parameters.\n-   **Objective**: The language is precise and quantitative. All terms are explicitly defined or are standard in the field.\n-   **Completeness**: All required data for the calculations ($[X]$, $K_D$, $c_{ij}$, $\\eta_j$, $\\tau$) are provided. There are no missing values.\n-   **Consistency**: There are no contradictions. The values of $c_{ij}$ are between $0$ and $1$, as expected for fractional inhibition. All constants are positive.\n\nThe problem is a self-contained, scientifically sound, and well-posed optimization task based on a biophysical model.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid**. A detailed solution will be provided.\n\n### Solution Derivation\n\nThe primary task is to find the antibody pair $(A_i, A_j)$ for capture and detection, respectively, that maximizes the net signal.\n\n**1. Formulation of the Objective Function**\nThe net objective is the difference between target-mediated signal and off-target background signal. Let the objective function for the pair $(A_i, A_j)$ be denoted $Z(i,j)$.\nThe signal for an antigen $X \\in \\{T, O\\}$ is proportional to the concentration of the sandwich complex $A_i-X-A_j$. The formation of this complex requires the antigen to be present at concentration $[X]$, and for both antibodies $A_i$ and $A_j$ to be bound. The probability of $A_k$ binding to $X$ is given by the fractional occupancy $\\theta_k^X$. The joint probability of forming a sandwich is modulated by the non-overlap factor $s_{ij}$. The signal is further scaled by the detection antibody's label efficiency $\\eta_j$.\nThus, the signal contribution from antigen $X$ can be modeled as:\n$$ S_X(i,j) = k \\cdot [X] \\cdot \\theta_i^X \\cdot \\theta_j^X \\cdot s_{ij} \\cdot \\eta_j $$\nwhere $k$ is an instrument-specific proportionality constant.\n\nThe net objective function is $Z(i,j) = S_T(i,j) - S_O(i,j)$.\n$$ Z(i,j) = k \\cdot \\eta_j \\cdot s_{ij} \\cdot ([T] \\theta_i^T \\theta_j^T - [O] \\theta_i^O \\theta_j^O) $$\nSince we are maximizing this function, the constant $k$ can be disregarded. We define the objective function to maximize as $Z'(i,j)$:\n$$ Z'(i,j) = \\eta_j \\cdot s_{ij} \\cdot ([T] \\theta_i^T \\theta_j^T - [O] \\theta_i^O \\theta_j^O) $$\n\n**2. Calculation of Non-Overlap Factors, $s_{ij}$**\nUsing the definition $s_{ij} = 1 - \\max(c_{ij}, c_{ji})$ for $i \\neq j$ and $s_{ii}=0$:\n-   $s_{12} = s_{21} = 1 - \\max(c_{12}, c_{21}) = 1 - \\max(0.60, 0.40) = 1 - 0.60 = 0.40$\n-   $s_{13} = s_{31} = 1 - \\max(c_{13}, c_{31}) = 1 - \\max(0.10, 0.05) = 1 - 0.10 = 0.90$\n-   $s_{23} = s_{32} = 1 - \\max(c_{23}, c_{32}) = 1 - \\max(0.70, 0.65) = 1 - 0.70 = 0.30$\n\nThe epitope compatibility matrix $S = [s_{ij}]$ is:\n$$ S = \\begin{pmatrix} 0 & 0.40 & 0.90 \\\\ 0.40 & 0 & 0.30 \\\\ 0.90 & 0.30 & 0 \\end{pmatrix} $$\n\n**3. Identification of Viable Pairs**\nViable pairs must satisfy the compatibility threshold $s_{ij} \\ge \\tau = 0.35$.\n-   $(A_1, A_2)$: $s_{12} = 0.40 \\ge 0.35 \\implies$ **Viable** ($p=1$).\n-   $(A_1, A_3)$: $s_{13} = 0.90 \\ge 0.35 \\implies$ **Viable** ($p=2$).\n-   $(A_2, A_1)$: $s_{21} = 0.40 \\ge 0.35 \\implies$ **Viable** ($p=3$).\n-   $(A_2, A_3)$: $s_{23} = 0.30 < 0.35 \\implies$ Not viable.\n-   $(A_3, A_1)$: $s_{31} = 0.90 \\ge 0.35 \\implies$ **Viable** ($p=5$).\n-   $(A_3, A_2)$: $s_{32} = 0.30 < 0.35 \\implies$ Not viable.\nThe viable oriented pairs to be evaluated are $(A_1, A_2)$, $(A_1, A_3)$, $(A_2, A_1)$, and $(A_3, A_1)$.\n\n**4. Calculation of Fractional Occupancies, $\\theta_i^X$**\nUsing the formula $\\theta_i^X = \\frac{[X]}{[X] + K_D^{(i,X)}}$, with $[T] = 2$ and $[O] = 10$.\n-   **For Target Antigen T**:\n    -   $\\theta_1^T = \\frac{2}{2 + 0.5} = \\frac{2}{2.5} = \\frac{4}{5} = 0.8$\n    -   $\\theta_2^T = \\frac{2}{2 + 2.0} = \\frac{2}{4} = \\frac{1}{2} = 0.5$\n    -   $\\theta_3^T = \\frac{2}{2 + 1.0} = \\frac{2}{3}$\n-   **For Off-Target Antigen O**:\n    -   $\\theta_1^O = \\frac{10}{10 + 30} = \\frac{10}{40} = \\frac{1}{4} = 0.25$\n    -   $\\theta_2^O = \\frac{10}{10 + 200} = \\frac{10}{210} = \\frac{1}{21}$\n    -   $\\theta_3^O = \\frac{10}{10 + 100} = \\frac{10}{110} = \\frac{1}{11}$\n\n**5. Evaluation of the Objective Function for Viable Pairs**\nWe calculate $Z'(i,j) = \\eta_j s_{ij} ([T] \\theta_i^T \\theta_j^T - [O] \\theta_i^O \\theta_j^O)$ for each viable pair.\n\n-   **Pair (1, 2)**: $i=1$, $j=2$, $p=1$. ($s_{12}=0.40$, $\\eta_2=1.3$)\n    $$ Z'(1,2) = (1.3)(0.40) \\left[ (2)\\left(\\frac{4}{5}\\right)\\left(\\frac{1}{2}\\right) - (10)\\left(\\frac{1}{4}\\right)\\left(\\frac{1}{21}\\right) \\right] $$\n    $$ Z'(1,2) = 0.52 \\left[ \\frac{4}{5} - \\frac{10}{84} \\right] = 0.52 \\left[ \\frac{4}{5} - \\frac{5}{42} \\right] = 0.52 \\left[ \\frac{168 - 25}{210} \\right] = 0.52 \\left( \\frac{143}{210} \\right) = \\frac{52}{100} \\frac{143}{210} = \\frac{13}{25} \\frac{143}{210} = \\frac{1859}{5250} $$\n\n-   **Pair (1, 3)**: $i=1$, $j=3$, $p=2$. ($s_{13}=0.90$, $\\eta_3=0.8$)\n    $$ Z'(1,3) = (0.8)(0.90) \\left[ (2)\\left(\\frac{4}{5}\\right)\\left(\\frac{2}{3}\\right) - (10)\\left(\\frac{1}{4}\\right)\\left(\\frac{1}{11}\\right) \\right] $$\n    $$ Z'(1,3) = 0.72 \\left[ \\frac{16}{15} - \\frac{10}{44} \\right] = 0.72 \\left[ \\frac{16}{15} - \\frac{5}{22} \\right] = 0.72 \\left[ \\frac{352 - 75}{330} \\right] = 0.72 \\left( \\frac{277}{330} \\right) = \\frac{72}{100} \\frac{277}{330} = \\frac{18}{25} \\frac{277}{330} = \\frac{3}{25} \\frac{277}{55} = \\frac{831}{1375} $$\n\n-   **Pair (2, 1)**: $i=2$, $j=1$, $p=3$. ($s_{21}=0.40$, $\\eta_1=1.0$)\n    $$ Z'(2,1) = (1.0)(0.40) \\left[ (2)\\left(\\frac{1}{2}\\right)\\left(\\frac{4}{5}\\right) - (10)\\left(\\frac{1}{21}\\right)\\left(\\frac{1}{4}\\right) \\right] $$\n    $$ Z'(2,1) = 0.40 \\left[ \\frac{4}{5} - \\frac{10}{84} \\right] = 0.40 \\left[ \\frac{143}{210} \\right] = \\frac{4}{10} \\frac{143}{210} = \\frac{2}{5} \\frac{143}{210} = \\frac{143}{525} $$\n\n-   **Pair (3, 1)**: $i=3$, $j=1$, $p=5$. ($s_{31}=0.90$, $\\eta_1=1.0$)\n    $$ Z'(3,1) = (1.0)(0.90) \\left[ (2)\\left(\\frac{2}{3}\\right)\\left(\\frac{4}{5}\\right) - (10)\\left(\\frac{1}{11}\\right)\\left(\\frac{1}{4}\\right) \\right] $$\n    $$ Z'(3,1) = 0.90 \\left[ \\frac{16}{15} - \\frac{10}{44} \\right] = 0.90 \\left[ \\frac{277}{330} \\right] = \\frac{9}{10} \\frac{277}{330} = \\frac{3}{10} \\frac{277}{110} = \\frac{831}{1100} $$\n\n**6. Selection of the Optimal Pair**\nWe now compare the numerical values of the objective function for the viable pairs.\n-   $Z'(1,2) = \\frac{1859}{5250} \\approx 0.3541$\n-   $Z'(1,3) = \\frac{831}{1375} \\approx 0.6044$\n-   $Z'(2,1) = \\frac{143}{525} \\approx 0.2724$\n-   $Z'(3,1) = \\frac{831}{1100} \\approx 0.7555$\n\nComparing the values:\n$$ 0.7555 > 0.6044 > 0.3541 > 0.2724 $$\n$$ Z'(3,1) > Z'(1,3) > Z'(1,2) > Z'(2,1) $$\nThe maximum value of the objective function is achieved for the pair $(A_3, A_1)$. This corresponds to using antibody $A_3$ as the capture reagent and antibody $A_1$ as the detection reagent.\n\nThe integer code for the optimal pair $(A_3, A_1)$ is $p=5$.",
            "answer": "$$\\boxed{5}$$"
        }
    ]
}